Literature DB >> 18594051

Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine.

Henry A Spiller, Jill Rk Griffith, Deborah L Anderson, Julie A Weber, Alfred Aleguas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18594051     DOI： 10.1345/aph.1L240

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  9 in total

1.  The value and evolving role of the U.S. Poison Control Center System.

Authors:  Henry A Spiller; Jill R K Griffith
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

2.  Alopecia following initiation of lisdexamfetamine in a pediatric patient.

Authors:  Nancy C Brahm; Donald R Hamilton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

3.  Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.

Authors:  Presenters Ornella Potter; Nadyah John; Discussant Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-10       Impact factor: 2.576

4.  New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.

Authors:  Diana Domnitei; Vishal Madaan
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

Review 5.  Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.

Authors:  Jadwiga Najib
Journal:  Adolesc Health Med Ther       Date:  2012-05-08

Review 6.  A systematic review of the safety of lisdexamfetamine dimesylate.

Authors:  David R Coghill; Beatriz Caballero; Shaw Sorooshian; Richard Civil
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

7.  Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine.

Authors:  Brian J Cowles
Journal:  Ther Clin Risk Manag       Date:  2009-12-29       Impact factor: 2.423

8.  Toxicology services in Libya: the present and the future.

Authors:  Roshan Saleh; Ashraf Kamour
Journal:  Libyan J Med       Date:  2014-04-01       Impact factor: 1.743

Review 9.  Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.

Authors:  Jadwiga Najib; Dexter Wimer; Julie Zeng; Kristina W Lam; Natalya Romanyak; Eva Paige Morgan; Anu Thadavila
Journal:  J Cent Nerv Syst Dis       Date:  2017-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.